Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate vs Bupropion for ADHD in Methadone Patients
NCT00061087Phase 3Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Feb 1998
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing METHYLPHENIDATE, BUPROPION and PLACEBO (3 arms). Primary endpoints: Cocaine use based on urine toxicology at 12 weeks and ADHD symptom severity based on the ADHD Rating scale score at 12 weeks. Started Feb 1998; status: completed.
02
Drugs
methylphenidatebupropion
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00061087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00061087.